期刊文献+

青少年多囊卵巢综合征与其父母代谢综合征的相关性研究 被引量:15

Study to the relationship of adolescent polycystic ovary syndrome with parental metabolic syndrome
下载PDF
导出
摘要 目的探讨青少年多囊卵巢综合征(PCOS)与其父母代谢综合征(MBS)的相关性。方法选择2004年3月—2007年3月在浙江省慈溪市妇幼保健院与慈溪市人民医院的36例PCOS青少年患者(11~16岁)及其父母(35例母亲,19例父亲)、21例正常青少年(女,11~16岁),进行其体质量指数(BMI)、腰围、血压测量,并检测其血清胆固醇(TC)、三酰甘油(TG)、雄性激素水平,同时进行糖耐量测定(OGTT)及超声检查多囊卵巢情况。结果①PCOS患者的父亲94%肥胖或超重,79%患有MBS。②PCOS患者的母亲停经前36%患MBS,明显高于患PCOS者(≤20%)。③PCOS患者的多囊卵巢特征极少数遗传于母亲,其主要遗传于父亲的MBS因素(P=0.008)。④PCOS患者中28%患有MBS。结论青少年PCOS在根本上是由其父亲患有MBS遗传因素所致。 Objective It is to approach the relationship of adolescent polycystic ovary syndrome(PCOS) phenotype with parental polycystic ovary syndrome(MBS).Methods 16 girls with PCOS(11 to 16 years old) and their parents(35 mothers and 19 fathers) both in the Maternity and Child Health Hospital of Cixi City and the People′s Hospital of Cixi City from March 2004 to March 2007 by choice,the body mass index(BMI),waistline,blood pressure of them were measured,and the levels of TC,TG,Testosterone of them were detected,as well as oral glucose tolerance test and polycystic ovary status detection by ultrasonic scanner were executed.And 21 healthy girls(11 to 16 years old) as reference were detected.Results ①94% fathers of girls with PCOS were obesity or overweight,and 79% were MBS.②36% premenopausal mothers of girls with PCOS were MBS,while only less than 22% were PCOS.③The polycystic ovary status in girls with PCOS were less heredity from their mothers,but capital heredity from their fathers′ MBS(P=0.008).④27.8% girls with PCOS were MBS.Conclusion Paternal MBS is the fundamental factor of their children′s PCOS.
作者 胡燕宁
出处 《现代中西医结合杂志》 CAS 2008年第3期335-337,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 多囊卵巢综合征 代谢综合征 青少年 父亲 母亲 polycystic ovary syndrome metabolic syndrome adolescent father mother
  • 相关文献

参考文献11

  • 1Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion[ J ]. Endocrin Rev, 1995,16 .312 - 322
  • 2Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population[J].J Clin Endocrinol Metab, 2004,89 : 2312 - 2745
  • 3Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome[J]. Diabetes 1989,38 ; 1123 - 1165
  • 4Ehrmann DA, Jeppe S,Byrne M, Karrison T, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus[ J ]. J Clin Invest, 1995,96 : 496 - 520
  • 5Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome[J]. Diabetes Care, 1999,22:130- 141
  • 6Legro RS,Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective, controlled study in 254 affected women [see comments] [J]. J Clin Endocrinol Metab, 1999,84:150 - 165
  • 7Glueck CJ,Papanna R, Wang P, et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome[J]. Metabolism,2003:859 - 908
  • 8Orio F, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study [J]. J Clin Endocrinol Metab, 2004 : 3600 - 3696
  • 9Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril, 2004,81:19- 25
  • 10Apridonidze T,Essah PA, luorno MJ,et al. Prevalence and characteristics of the metabolic symdrome in women with polycystic ovary syndrome [ J ]. J Clin Endocrinol Metab, 2005,90 : 35 - 40

二级参考文献10

  • 1Diamanti KE ,Kouli CR,Bergiele AT,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile [ J ]. J Clin Endocrinol Metab, 1999,84 :4006-4011.
  • 2Zhang LH, Rodriguez H, Ohno S, et al. Serine phosphorylation of human P450c17 increases 17,20-1yase activity : implications for adrenarche and the polycystic ovary syndrome [ J ]. Proe Nail Acad Sci USA,1995,92:10619-10623.
  • 3Taylor AE, McCourt B, Martin K, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with PCOS[ J ]. J Clin Endocrinol Metab, 1997,82:2248-2256.
  • 4Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome [ J ]. Endocrinol Metab Clin North Am, 1999,28 : 265-293.
  • 5Jakimiuk AJ, Weitsman SR, Navab A, et al. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries[J]. J Clin Endocrinol Metab,2001,86 : 1318 -1323.
  • 6Nestler JE, Jakubowicz D J, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system [ J ]. J Clin Endocrinol Metab ,1998,83:2001-2005.
  • 7Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence[ J]. Endocrinol Metab Clin North Am,2005,34:677-705.
  • 8The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [ J ].Hum Reprod ,2004,19:41-47.
  • 9Sheehan MT. Polycystic ovarian syndrome:diagnosis and management[ J]. Clin Med Res,2004,2( 1 ) :13-27.
  • 10翟军,阮祥燕.多囊卵巢综合征临床治疗进展[J].实用妇产科杂志,2004,20(2):74-76. 被引量:23

共引文献3

同被引文献166

引证文献15

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部